Rutella Lab

CONGRESS | #ASH23 | Sergio Rutella, @TrentUni shares data on W-NK, concluding that W-NK cells are effective against AML cells under culture conditions to mimic hypoxia and immunosuppressive TME. W-NK is also observed to persist in BM tissues, to control AML in vivo. #AMLsm #leusm

Immunogenomic landscape of p53 AML. Sergio Rutella, M.D., Ph.D., Nottingham University, UK. April 26th, Genomic Workshop &Hem Malig symposium. Georgetown MedStar Unv. hospital. Register eventbrite.com/e/genomics-wor…. @ASH_hematology @LombardiCancer @BCMCancerCenter @leukaemielabor

Farhad Ravandi, M.D., AML MRD optimization before BMT, MD Anderson CC. April 27th, 10:50 am. Goldberg auditorium, MGHU. Register: eventbrite.com/e/genomics-wor… @LombardiCancer @BCMCancerCenter @aamdsif @LLSusa @leukaemielabor @ASH_hematology @SocietyofHemOnc @HMHNewJersey

#EBMT21 Leo Luznik on the results of the BMT CTN 1301 trial comparing calcineurin inhibitor-free GVHD prophylaxis in HCT recipients who received myeloablative conditioning & had HLA-matched donors #bmtsm (2/2)

#EBMT21 Leo Luznik on the results of the BMT CTN 1301 trial comparing calcineurin inhibitor-free GVHD prophylaxis in HCT recipients who received myeloablative conditioning & had HLA-matched donors #bmtsm (1/2)

Escape from T-cell targeting immunotherapies in acute myeloid leukemia ashpublications.org/blood/article-…

Escape from T-cell targeting immunotherapies in acute myeloid leukemia ashpublications.org/blood/article-…

Check this out! Closing date: 30th June 2023. lnkd.in/eTczg3-a

Open PhD position in my lab. Check it out! #phdstudent #phd #immunooncology #immunotherapy #ash_hematology #cancerresearch lnkd.in/eWxBWaGf

I am hiring! Just reach out to discuss, if you think you have the right skills and expertise. #hiring #ash_hematology #immunology #immunotherapy lnkd.in/dtnkaAhn

Great to see very broad coverage of our AML work and an Altmetric score of 1,174! #ash_hematology #ash22 #immunotherapy #immunooncology #nottinghamtrentuniversity lnkd.in/d7U8mHZr

#bsh_haematology #ash_hematology #ash22 lnkd.in/eA9GjmNH

Fighting aggressive blood cancer ages and exhausts immune cells, study suggests independent.co.uk/news/uk/patien…

Our T-cell dysfunction/senescence paper is finally out! #ASH22 @ash_hematology lnkd.in/d5SCUCeC

Signatures of immune dysfunction predict outcomes and define checkpoint blockade-unresponsive microenvironments in … pubmed.ncbi.nlm.nih.gov/36099049/

ESMO Congress 2022: LIVE Plus Prof. Solange Peters, ESMO President 2020-... youtu.be/ARQyVS-hR4c via @YouTube

Why the party is over for Britain’s Research Excellence Framework nature.com/articles/d4158…

Research Fellow - Nottingham Trent University vacancies.ntu.ac.uk/displayjob.asp…

Signatures of immune senescence predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia medrxiv.org/content/10.110…

#ESMOImmuno21: Your chance to help us shape the future of immuno-oncology. Watch Kevin Harrington explain why you can’t miss this event and register to participate online. 👉 ow.ly/BxBF50GXhe7 #immunooncology #immunotherapy #cancerresearch #immunonc